Is Royalty Pharma plc a good dividend stock?

Royalty Pharma plc (RPRX) is a dividend-paying stock with a current dividend yield of 1.56%. Review its dividend history, payout consistency and growth to judge whether it fits your income strategy.

What is RPRX's dividend yield?

The dividend yield for RPRX stock is currently 1.56%.

How much does RPRX pay in dividends per year?

Royalty Pharma plc pays an annual dividend of $0.9100 per share over the trailing twelve months.

How often does RPRX pay dividends?

RPRX stock pays dividends quarterly.

Is RPRX's dividend growing?

Royalty Pharma plc's 3-year dividend CAGR is 5.27%.

RPRX Stock Price, Chart, Stats & News

Royalty Pharma plc

Save

Overview Dividend safety Dividends Fundamentals

Royalty Pharma plc (RPRX) is a dividend-paying stock with a current dividend yield of 1.56% as of Jul 17, 2026. It pays $0.9100 per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 7.29% 5-year compound annual rate.

25.02B

Market cap

11.48x

Current P/E

46.73x

Forward P/E

1.56%

Dividend yield

$0.9100

RPRX dividend

Dividend safety

Strong

Dividend coverage looks healthy — RPRX pays out about 18% of earnings.

See the safety analysis

RPRX chart

Loading chart...

Fundamentals

Gross margin	100.00%
Operating margin	65.58%
Pretax margin	55.68%
Net margin	32.42%
Effective tax rate	–
ROA	3.93%
ROE	11.89%
D/E	1.38x
Interest coverage ratio	5.07x

All financials

RPRX valuation

P/E	11.48x
P/S	8.35x
P/B	3.09x
P/CF	8.04x
P/FCF	7.98x
P/OCF	8.04x
PEG	2.72x
EV multiple	7.05x

About

Health care

Sector

Medical - Pharmaceuticals

Industry

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.